CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.100
-0.070 (-3.23%)
At close: Aug 7, 2025, 4:00 PM
2.020
-0.080 (-3.81%)
After-hours: Aug 7, 2025, 7:56 PM EDT

Paycor HCM Stock Forecast

Stock Price Forecast

The 3 analysts that cover Paycor HCM stock have a consensus rating of "Strong Buy" and an average price target of $5.67, which forecasts a 170.00% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $7.00.

Price Target: $5.67 (+170.00%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$5.00$5.67$5.00$7.00
Change+138.10%+170.00%+138.10%+233.33%

Analyst Ratings

The average analyst rating for Paycor HCM stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111111
Buy221122
Hold330000
Sell000000
Strong Sell000000
Total662233

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Initiates
$7
BuyInitiates$7+233.33%Jul 31, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong BuyReiterates$5+138.10%May 20, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$2.5$5
BuyMaintains$2.5$5+138.10%May 15, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$5
Strong BuyUpgrades$5+138.10%May 15, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$3.25$2.5
BuyMaintains$3.25$2.5+19.05%Apr 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
90.03M
from 138.10M
Decreased by -34.81%
Revenue Next Year
55.23M
from 90.03M
Decreased by -38.66%
EPS This Year
-0.22
from 0.38
EPS Next Year
-0.42
from -0.22
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
68.43M37.31M53.16M101.21M138.10M90.03M55.23M18.19M
Revenue Growth
154.36%-45.47%42.48%90.38%36.45%-34.81%-38.66%-67.06%
EPS
-1.40-1.81-1.51-0.010.38-0.22-0.42-0.65
EPS Growth
--------
Forward PE
--------
No. Analysts
-----885
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High132.3M126.0M52.5M
Avg90.0M55.2M18.2M
Low61.7Mn/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
-4.2%
39.9%
-4.9%
Avg
-34.8%
-38.7%
-67.1%
Low
-55.4%
--

EPS Forecast

EPS20252026202720282029
High-0.15-0.01-0.53
Avg-0.22-0.42-0.65
Low-0.32-0.69-0.74

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.